In last trading session, Acrivon Therapeutics Inc (NASDAQ:ACRV) saw 0.38 million shares changing hands with its beta currently measuring 1.27. Company’s recent per share price level of $9.59 trading at $1.13 or 13.36% at ring of the bell on the day assigns it a market valuation of $296.14M. That closing price of ACRV’s stock is at a discount of -49.11% from its 52-week high price of $14.30 and is indicating a premium of 66.74% from its 52-week low price of $3.19. Taking a look at company’s average trading volume volume of 783.66K if we extend that period to 3-months.

Acrivon Therapeutics Inc (NASDAQ:ACRV) trade information

Upright in the green during last session for gaining 13.36%, in the last five days ACRV remained trading in the green while hitting it’s week-highest on Friday, 05/03/24 when the stock touched $9.59 price level, adding 6.8% to its value on the day. Acrivon Therapeutics Inc’s shares saw a change of 94.92% in year-to-date performance and have moved 13.36% in past 5-day. Acrivon Therapeutics Inc (NASDAQ:ACRV) showed a performance of 43.35% in past 30-days.

Acrivon Therapeutics Inc (ACRV) estimates and forecasts

Statistics highlight that Acrivon Therapeutics Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company added 88.78% of value to its shares in past 6 months, showing an annual growth rate of -11.31% while that of industry is 11.50. Apart from that, the company came lowering its revenue forecast for fiscal year 2024.

ACRV Dividends

Acrivon Therapeutics Inc is more likely to be releasing its next quarterly report in June and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.